Published in J Photochem Photobiol B on February 11, 2010
Photodynamic and Antibiotic Therapy in Combination to Fight Biofilms and Resistant Surface Bacterial Infections. Int J Mol Sci (2015) 0.85
Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Photochem Photobiol (2011) 0.83
Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother (2012) 0.83
Hydrogen bond acceptors and additional cationic charges in methylene blue derivatives: photophysics and antimicrobial efficiency. Biomed Res Int (2012) 0.78
Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy. Front Microbiol (2016) 0.75
Enhancement of photodynamic inactivation of Staphylococcus aureus biofilms by disruptive strategies. Lasers Med Sci (2017) 0.75
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One (2012) 2.03
Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol (2005) 1.75
Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano (2013) 1.58
Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials (2003) 1.50
CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology (2005) 1.28
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol (2011) 1.27
Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res (2011) 1.21
Antifungal photodynamic therapy. Microbiol Res (2007) 1.20
Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci (2013) 1.18
Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci (2013) 1.17
Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res (2009) 1.14
Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol In Vitro (2010) 1.10
Mucoadhesive drug delivery systems. J Pharm Bioallied Sci (2011) 1.07
Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B (2006) 1.07
Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc (2009) 1.00
Anti-adherent and antifungal activities of surfactant-coated poly(ethylcyanoacrylate) nanoparticles. Int J Pharm (2007) 0.98
Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm (2012) 0.96
Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release (2012) 0.96
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Drug delivery strategies for photodynamic antimicrobial chemotherapy: from benchtop to clinical practice. J Photochem Photobiol B (2009) 0.95
Molecular detection of CF lung pathogens: current status and future potential. J Cyst Fibros (2013) 0.95
Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv (2012) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
Physical characterisation and component release of poly(vinyl alcohol)-tetrahydroxyborate hydrogels and their applicability as potential topical drug delivery systems. Int J Pharm (2011) 0.93
Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. J Microencapsul (2006) 0.93
Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul (2010) 0.91
Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv (2008) 0.91
Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. Future Med Chem (2009) 0.91
Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul (2011) 0.90
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis. J Antimicrob Chemother (2013) 0.88
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol (2012) 0.88
Electrically enhanced solute permeation across poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: effect of hydrogel crosslink density and ionic conductivity. Int J Pharm (2011) 0.88
Investigation of solute permeation across hydrogels composed of poly(methyl vinyl ether-co-maleic acid) and poly(ethylene glycol). J Pharm Pharmacol (2010) 0.88
The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv (2014) 0.87
Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices (2011) 0.87
Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Eur J Pharm Biopharm (2012) 0.87
Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions. PLoS One (2013) 0.87
Development of novel oral formulations prepared via hot melt extrusion for targeted delivery of photosensitizer to the colon. Photochem Photobiol (2011) 0.86
Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res (2015) 0.85
Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection. J Photochem Photobiol B (2011) 0.85
Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: a potential means of photodynamic therapy of infected wounds. J Photochem Photobiol B (2009) 0.85
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions. J Cyst Fibros (2011) 0.85
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles. Pharm Res (2007) 0.85
Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release (2012) 0.85
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles. Biomacromolecules (2013) 0.84
Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res A (2008) 0.84
Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions. Antimicrob Agents Chemother (2013) 0.84
Novel patch-based systems for the localised delivery of ALA-esters. J Photochem Photobiol B (2010) 0.84
The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection. Expert Rev Respir Med (2013) 0.84
Macrolides and bronchiectasis: clinical benefit with a resistance price. JAMA (2013) 0.83
Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur J Pharm Biopharm (2008) 0.83
Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination. J Pharm Pharmacol (2014) 0.83
Microneedle-mediated transdermal bacteriophage delivery. Eur J Pharm Sci (2012) 0.83
Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol (2004) 0.83
Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res (2015) 0.82
Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulm Med (2014) 0.82
Paediatricians' opinions of microneedle-mediated monitoring: a key stage in the translation of microneedle technology from laboratory into clinical practice. Drug Deliv Transl Res (2015) 0.82
Children's views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract (2013) 0.82
Strategies for enhanced peptide and protein delivery. Ther Deliv (2013) 0.81
Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur J Pharm Sci (2005) 0.81
Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials (2004) 0.80
Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation. J Pharm Biomed Anal (2005) 0.80
Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. J Control Release (2006) 0.80
In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. Eur J Pharm Biopharm (2006) 0.80
Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.79
Microneedles: an innovative platform for gene delivery. Drug Deliv Transl Res (2015) 0.79
The potential for human exposure, direct and indirect, to the suspected carcinogenic triphenylmethane dye Brilliant Green from green paper towels. Food Chem Toxicol (2011) 0.78
Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm (2005) 0.77
Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed (2009) 0.77
Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy. Photodermatol Photoimmunol Photomed (2008) 0.77
Comparison of a novel spray congealing procedure with emulsion-based methods for the micro-encapsulation of water-soluble drugs in low melting point triglycerides. J Microencapsul (2008) 0.77
Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias. Pharm Res (2007) 0.77
Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: a pilot study. Photodiagnosis Photodyn Ther (2011) 0.77
Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol (2012) 0.77
The role of anaerobic bacteria in the cystic fibrosis airway. Curr Opin Pulm Med (2016) 0.76
Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics. Int J Pharm (2012) 0.76
Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy. J Photochem Photobiol B (2012) 0.76
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses. J Pharm Sci (2010) 0.76
Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. J Pharm Sci (2005) 0.75
Improving prescribing of antibiotics in long-term care: resistant to change? JAMA Intern Med (2013) 0.75
Innovative drug delivery strategies for topical photodynamic therapy using porphyrin precursors. J Environ Pathol Toxicol Oncol (2007) 0.75
Phototoxicity of 5-aminolevulinic acid in the HeLa cell line as an indicative measure of photodynamic effect after topical administration to gynecological lesions of intraepithelial form. Pharm Res (2004) 0.75
Preface. Recent Pat Drug Deliv Formul (2016) 0.75
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches. J Pharm Pharmacol (2010) 0.75
Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy. J Pharm Pharmacol (2009) 0.75
Preaggregated Ag nanoparticles in dry swellable gel films for off-the-shelf surface-enhanced Raman spectroscopy. Anal Chem (2014) 0.75
Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery. J Pharm Pharmacol (2013) 0.75
Novel bioadhesive patch-type system for photodynamic vulvodynia therapy after delivery of 5-aminolevulinic acid: preliminary evaluation. J Reprod Med (2007) 0.75
Formulation and characterization of poly(ethylene glycol)-based, 5-aminolevulinic acid-loaded solid-dosage forms intended for photodynamic and photodiagnostic methodologies in the colorectal region. J Environ Pathol Toxicol Oncol (2007) 0.75